Trial intelligence / Profile preview

Simplified Kaletra vs Sustiva in HIV

NCT00075231Phase 2Completed

Sponsor
Abbott Laboratories
Start
Dec 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Abbott Laboratories. Started Dec 2003; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00075231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00075231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call